Literature DB >> 34260701

Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia.

Eleanor C Semmes1,2,3, Shuk Hang Li2, Jillian H Hurst4,3, Zidanyue Yang5, Donna Niedzwiecki5, Genevieve G Fouda2,4,3, Joanne Kurtzberg6, Kyle M Walsh3,7, Sallie R Permar2,3,8.   

Abstract

BACKGROUND: Placentally transferred maternal immunoglobulin G (IgG) protects against pathogens in early life, yet vertically transmitted infections can interfere with transplacental IgG transfer. Although human cytomegalovirus (HCMV) is the most common placentally-transmitted viral infection worldwide, the impact of congenital HCMV (cCMV) infection on transplacental IgG transfer has been underexplored.
METHODS: We evaluated total and antigen-specific maternal and cord blood IgG levels and transplacental IgG transfer efficiency in a US-based cohort of 93 mother-infant pairs including 27 cCMV-infected and 66 cCMV-uninfected pairs, of which 29 infants were born to HCMV-seropositive nontransmitting mothers and 37 to HCMV-seronegative mothers. Controls were matched on sex, race/ethnicity, maternal age, and delivery year.
RESULTS: Transplacental IgG transfer efficiency was decreased by 23% (95% confidence interval [CI] 10-36%, P = .0079) in cCMV-infected pairs and 75% of this effect (95% CI 28-174%, P = .0085) was mediated by elevated maternal IgG levels (ie, hypergammaglobulinemia) in HCMV-transmitting women. Despite reduced transfer efficiency, IgG levels were similar in cord blood from infants with and without cCMV infection.
CONCLUSIONS: Our results indicate that cCMV infection moderately reduces transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia; however, infants with and without cCMV infection had similar antigen-specific IgG levels, suggesting comparable protection from maternal IgG acquired via transplacental transfer.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  congenital CMV infection; human cytomegalovirus; maternal hypergammaglobulinemia; maternal-fetal vaccination; transplacental IgG transfer

Mesh:

Substances:

Year:  2022        PMID: 34260701      PMCID: PMC8994583          DOI: 10.1093/cid/ciab627

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  40 in total

1.  Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.

Authors:  Marisa Márcia Mussi-Pinhata; Patrícia Cristina Gomes Pinto; Aparecida Yulie Yamamoto; Klara Berencsi; Cleonice Barbosa Sandoval de Souza; Mauro Andrea; Geraldo Duarte; Salim Moyses Jorge
Journal:  J Med Virol       Date:  2003-02       Impact factor: 2.327

2.  Hyperimmunoglobulin for prevention of congenital cytomegalovirus disease.

Authors:  Giovanni Nigro; Stuart P Adler
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

3.  In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia.

Authors:  Stephen Starko Francis; Amelia D Wallace; George A Wendt; Linlin Li; Fenyong Liu; Lee W Riley; Scott Kogan; Kyle M Walsh; Adam J de Smith; Gary V Dahl; Xiaomei Ma; Eric Delwart; Catherine Metayer; Joseph L Wiemels
Journal:  Blood       Date:  2016-12-15       Impact factor: 22.113

4.  Fc Glycan-Mediated Regulation of Placental Antibody Transfer.

Authors:  Madeleine F Jennewein; Ilona Goldfarb; Sepideh Dolatshahi; Cormac Cosgrove; Francesca J Noelette; Marina Krykbaeva; Jishnu Das; Aniruddh Sarkar; Matthew J Gorman; Stephanie Fischinger; Carolyn M Boudreau; Joelle Brown; Jennifer H Cooperrider; Jasneet Aneja; Todd J Suscovich; Barney S Graham; Georg M Lauer; Tessa Goetghebuer; Arnaud Marchant; Douglas Lauffenburger; Arthur Y Kim; Laura E Riley; Galit Alter
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

5.  The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population.

Authors:  B J Okoko; L H Wesumperuma; M O Ota; M Pinder; W Banya; S F Gomez; K P McAdam; A C Hart
Journal:  J Infect Dis       Date:  2001-07-31       Impact factor: 5.226

6.  The Impact of IgG transplacental transfer on early life immunity.

Authors:  Genevieve G Fouda; David R Martinez; Geeta K Swamy; Sallie R Permar
Journal:  Immunohorizons       Date:  2018-01-01

7.  Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Authors:  Cody S Nelson; Diana Vera Cruz; Dollnovan Tran; Kristy M Bialas; Lisa Stamper; Huali Wu; Margaret Gilbert; Robert Blair; Xavier Alvarez; Hannah Itell; Meng Chen; Ashlesha Deshpande; Flavia Chiuppesi; Felix Wussow; Don J Diamond; Nathan Vandergrift; Mark R Walter; Peter A Barry; Michael Cohen-Wolkowiez; Katia Koelle; Amitinder Kaur; Sallie R Permar
Journal:  JCI Insight       Date:  2017-07-06

8.  The repertoire of maternal anti-viral antibodies in human newborns.

Authors:  Christian Pou; Dieudonné Nkulikiyimfura; Ewa Henckel; Axel Olin; Tadepally Lakshmikanth; Jaromir Mikes; Jun Wang; Yang Chen; Anna Karin Bernhardsson; Anna Gustafsson; Kajsa Bohlin; Petter Brodin
Journal:  Nat Med       Date:  2019-03-18       Impact factor: 53.440

9.  Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor.

Authors:  Xiaoyang Liu; Senthilkumar Palaniyandi; Iowis Zhu; Jin Tang; Weizhong Li; Xiaoling Wu; Susan Park Ochsner; C David Pauza; Jeffrey I Cohen; Xiaoping Zhu
Journal:  Nat Commun       Date:  2019-07-09       Impact factor: 14.919

10.  A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.

Authors:  Brenna L Hughes; Rebecca G Clifton; Dwight J Rouse; George R Saade; Mara J Dinsmoor; Uma M Reddy; Robert Pass; Donna Allard; Gail Mallett; Lida M Fette; Cynthia Gyamfi-Bannerman; Michael W Varner; William H Goodnight; Alan T N Tita; Maged M Costantine; Geeta K Swamy; Ronald S Gibbs; Edward K Chien; Suneet P Chauhan; Yasser Y El-Sayed; Brian M Casey; Samuel Parry; Hyagriv N Simhan; Peter G Napolitano; George A Macones
Journal:  N Engl J Med       Date:  2021-07-29       Impact factor: 91.245

View more
  1 in total

1.  Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.

Authors:  Eleanor C Semmes; Itzayana G Miller; Courtney E Wimberly; Caroline T Phan; Jennifer A Jenks; Melissa J Harnois; Stella J Berendam; Helen Webster; Jillian H Hurst; Joanne Kurtzberg; Genevieve G Fouda; Kyle M Walsh; Sallie R Permar
Journal:  J Clin Invest       Date:  2022-08-15       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.